{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:23:50Z","timestamp":1790652230581,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00134-024-07454-z","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T04:02:05Z","timestamp":1715745725000},"page":"849-860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of hematological patients requiring emergency chemotherapy in the intensive care unit"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-5728","authenticated-orcid":false,"given":"Antoine","family":"Lafarge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Chean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Clere-Jehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Groupe de Recherche en R\u00e9animation Respiratoire du patient d\u2019Onco-H\u00e9matologie (GRRR-OH)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamel","family":"Mokart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lemiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u00efke","family":"Big\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Bisbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Demoule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Kouatchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Mayaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Nyunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"P\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfa","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Mourvillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Clinical Research in Intensive Care and Sepsis - TRIal Group for Global Evaluation and Research in SEPsis (CRICS-TRIGGERSEP)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Asfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Plantefeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Badie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Sedillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Wittebole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Mira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Rigaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Louis","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Quenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Foret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Heming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Bulpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Clere-Jehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Lacherade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenha\u00ebl","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Nigeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Grunderbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Guervilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Monchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Roustan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toufik","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Schryver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Frat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Chatelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Barbarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Legay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Dangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Audibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa\u00ebl","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Joganah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Chelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Ducros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Reizine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Delbove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Bavozet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Simon","family":"Pugliesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Maldiney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shidasp","family":"Siami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Tissi\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gibot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"7454_CR1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00277-014-2141-x","volume":"93","author":"P Wohlfarth","year":"2014","unstructured":"Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, Laczika K, Carlstrom A, Riss K, Rabitsch W, Bojic M, Knoebl P, Locker GJ, Obiditsch M, Fuhrmann V, Schellongowski P, Arbeitsgruppe fur hamato-onkologische Intensivmedizin der Osterreichischen Gesellschaft fur Internistische und Allgemeine Intensivmedizin und N (2014) Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol 93:1629\u20131636","journal-title":"Ann Hematol"},{"key":"7454_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00134-005-2836-5","volume":"32","author":"DD Benoit","year":"2006","unstructured":"Benoit DD, Depuydt PO, Vandewoude KH, Offner FC, Boterberg T, De Cock CA, Noens LA, Janssens AM, Decruyenaere JM (2006) Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 32:93\u201399","journal-title":"Intensive Care Med"},{"key":"7454_CR3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00520-010-0841-x","volume":"19","author":"JU Song","year":"2011","unstructured":"Song JU, Suh GY, Chung MP, Kim H, Kwon OJ, Jung CW, Kang WK, Park K, Jeon K (2011) Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit. Support Care Cancer 19:491\u2013495","journal-title":"Support Care Cancer"},{"key":"7454_CR4","first-page":"559","volume":"21","author":"I Moors","year":"2015","unstructured":"Moors I, Pene F, Lengline E, Benoit D (2015) Urgent chemotherapy in hematological patients in the ICU. Curr Opin Crit Care 21:559\u2013568","journal-title":"Curr Opin Crit Care"},{"key":"7454_CR5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-008-1002-2","volume":"34","author":"DM Vandijck","year":"2008","unstructured":"Vandijck DM, Benoit DD, Depuydt PO, Offner FC, Blot SI, Van Tilborgh AK, Nollet J, Steel E, Noens LA, Decruyenaere JM (2008) Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 34:847\u2013855","journal-title":"Intensive Care Med"},{"key":"7454_CR6","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1002\/cncr.31409","volume":"124","author":"SM Pastores","year":"2018","unstructured":"Pastores SM, Goldman DA, Shaz DJ, Kostelecky N, Daley RJ, Peterson TJ, Tan KS, Halpern NA (2018) Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit. Cancer 124:3025\u20133036","journal-title":"Cancer"},{"key":"7454_CR7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3109\/10428194.2011.649752","volume":"53","author":"E Lengline","year":"2012","unstructured":"Lengline E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, Schlemmer B, Dombret H, Azoulay E (2012) Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 53:1352\u20131359","journal-title":"Leuk Lymphoma"},{"key":"7454_CR8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0885066617748602","volume":"35","author":"MCF de Oliveira","year":"2020","unstructured":"de Oliveira MCF, Ferreira JC, Nassar Junior AP, Dettino ALA, Caruso P (2020) Impact of urgent chemotherapy in critically ill patients. J Intensive Care Med 35:347\u2013353","journal-title":"J Intensive Care Med"},{"key":"7454_CR9","doi-asserted-by":"crossref","first-page":"e640","DOI":"10.1097\/CCM.0000000000002331","volume":"45","author":"Y Zerbib","year":"2017","unstructured":"Zerbib Y, Rabbat A, Fartoukh M, Bige N, Andrejak C, Mayaux J, De Prost N, Misset B, Lemiale V, Bruneel F, Maizel J, Ricome S, Jacobs F, Bornstain C, Dupont H, Baudin F, Azoulay E, Pene F, Groupe de Recherche sur la Reanimation Respiratoire en O-H (2017) Urgent chemotherapy for life-threatening complications related to solid neoplasms. Crit Care Med 45:e640\u2013e648","journal-title":"Crit Care Med"},{"key":"7454_CR10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2008-05-157065","volume":"113","author":"MA Sekeres","year":"2009","unstructured":"Sekeres MA, Elson P, Kalaycio ME, Advani AS, Copelan EA, Faderl S, Kantarjian HM, Estey E (2009) Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood 113:28\u201336","journal-title":"Blood"},{"key":"7454_CR11","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/bloodadvances.2017005561","volume":"1","author":"EJ Vick","year":"2017","unstructured":"Vick EJ, Patel K, Prouet P, Martin MG (2017) Proliferation through activation: hemophagocytic lymphohistiocytosis in hematologic malignancy. Blood Adv 1:779\u2013791","journal-title":"Blood Adv"},{"key":"7454_CR12","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373:1136\u20131152","journal-title":"N Engl J Med"},{"key":"7454_CR13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00277-023-05205-6","volume":"102","author":"C Desprez","year":"2023","unstructured":"Desprez C, Kouatchet A, Marchand T, Mear JB, Tadie JM, Peterlin P, Chevalier P, Canet E, Couturier MA, Guillerm G, Bodenes L, Gyan E, Villate A, Ehrmann S, Lebreton A, Lester MA, Fronteau C, Larhantec G, Andre V, Riou J, Hunault-Berger M, Schmidt-Tanguy A, Orvain C (2023) Outcome of patients with newly diagnosed AML admitted to the ICU, including preemptive admission\u2014a multi-center study. Ann Hematol 102:1383\u20131393","journal-title":"Ann Hematol"},{"key":"7454_CR14","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1080\/10428194.2022.2056178","volume":"63","author":"W Macaron","year":"2022","unstructured":"Macaron W, Sargsyan Z, Short NJ (2022) Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leuk Lymphoma 63:1780\u20131791","journal-title":"Leuk Lymphoma"},{"key":"7454_CR15","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1038\/s41375-020-0783-3","volume":"34","author":"M Stahl","year":"2020","unstructured":"Stahl M, Shallis RM, Wei W, Montesinos P, Lengline E, Neukirchen J, Bhatt VR, Sekeres MA, Fathi AT, Konig H, Luger S, Khan I, Roboz GJ, Cluzeau T, Martinez-Cuadron D, Raffoux E, Germing U, Umakanthan JM, Mukherjee S, Brunner AM, Miller A, McMahon CM, Ritchie EK, Rodriguez-Veiga R, Itzykson R, Boluda B, Rabian F, Tormo M, Acuna-Cruz E, Rabinovich E, Yoo B, Cano I, Podoltsev NA, Bewersdorf JP, Gore S, Zeidan AM (2020) Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia 34:3149\u20133160","journal-title":"Leukemia"},{"key":"7454_CR16","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","volume":"99","author":"C Thiede","year":"2002","unstructured":"Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, Wermke M, Bornhauser M, Ritter M, Neubauer A, Ehninger G, Illmer T (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99:4326\u20134335","journal-title":"Blood"},{"key":"7454_CR17","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3390\/cells9102310","volume":"9","author":"JP Bewersdorf","year":"2020","unstructured":"Bewersdorf JP, Zeidan AM (2020) Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments? Cells 9:2310","journal-title":"Cells"},{"key":"7454_CR18","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.V97.7.2121","volume":"97","author":"A Stucki","year":"2001","unstructured":"Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O (2001) Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 97:2121\u20132129","journal-title":"Blood"},{"key":"7454_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.V38.3.299.299","volume":"38","author":"MH Steinberg","year":"1971","unstructured":"Steinberg MH, Charm SE (1971) Effect of high concentrations of leukocytes on whole blood viscosity. Blood 38:299\u2013301","journal-title":"Blood"},{"key":"7454_CR20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2141.1997.1943011.x","volume":"98","author":"P Porcu","year":"1997","unstructured":"Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, McCarthy LJ (1997) Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 98:433\u2013436","journal-title":"Br J Haematol"},{"key":"7454_CR21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005285","volume":"95","author":"M Stefanski","year":"2016","unstructured":"Stefanski M, Jamis-Dow C, Bayerl M, Desai RJ, Claxton DF, Van de Louw A (2016) Chest radiographic and CT findings in hyperleukocytic acute myeloid leukemia: a retrospective cohort study of 73 patients. Medicine (Baltimore) 95:e5285","journal-title":"Medicine (Baltimore)"},{"key":"7454_CR22","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3109\/10428194.2014.887709","volume":"55","author":"AS Moreau","year":"2014","unstructured":"Moreau AS, Lengline E, Seguin A, Lemiale V, Canet E, Raffoux E, Schlemmer B, Azoulay E (2014) Respiratory events at the earliest phase of acute myeloid leukemia. Leuk Lymphoma 55:2556\u20132563","journal-title":"Leuk Lymphoma"},{"key":"7454_CR23","first-page":"3020","volume":"7","author":"AA Algharras","year":"2013","unstructured":"Algharras AA, Mamourian A, Coyne T, Mohan S (2013) Leukostasis in an adult with AML presenting as multiple high attenuation brain masses on CT. J Clin Diagn Res 7:3020\u20133022","journal-title":"J Clin Diagn Res"},{"key":"7454_CR24","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3109\/10428194.2016.1142083","volume":"57","author":"AC Mamez","year":"2016","unstructured":"Mamez AC, Raffoux E, Chevret S, Lemiale V, Boissel N, Canet E, Schlemmer B, Dombret H, Azoulay E, Lengline E (2016) Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia. Leuk Lymphoma 57:2281\u20132288","journal-title":"Leuk Lymphoma"},{"key":"7454_CR25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/10428194.2019.1683735","volume":"61","author":"M Cerrano","year":"2020","unstructured":"Cerrano M, Seegers V, Raffoux E, Rabian F, Sebert M, Itzykson R, Lemiale V, Ades L, Boissel N, Dombret H, Azoulay E, Lengline E (2020) Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis. Leuk Lymphoma 61:737\u2013740","journal-title":"Leuk Lymphoma"},{"key":"7454_CR26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, Rollig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, Lowenberg B (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140:1345\u20131377","journal-title":"Blood"},{"key":"7454_CR27","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1080\/10428194.2018.1452219","volume":"59","author":"M Stahl","year":"2018","unstructured":"Stahl M, Pine A, Hendrickson JE, Litzow MR, Luger SM, Stone RM, Erba HP, Kim TK, Sekeres MA, Steensma DP, Komrokji RS, Gore SD, Zeidan AM (2018) Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey(). Leuk Lymphoma 59:2723\u20132726","journal-title":"Leuk Lymphoma"},{"key":"7454_CR28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ajh.2830270109","volume":"27","author":"GJ Ventura","year":"1988","unstructured":"Ventura GJ, Hester JP, Smith TL, Keating MJ (1988) Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction. Am J Hematol 27:34\u201337","journal-title":"Am J Hematol"},{"key":"7454_CR29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/10428194.2020.1856835","volume":"62","author":"J Zhao","year":"2021","unstructured":"Zhao J, Bewersdorf JP, Jaszczur S, Kowalski A, Perreault S, Schiffer M, Gore S, Podoltsev N, Prebet T, Shallis R, Zeidan AM (2021) High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis. Leuk Lymphoma 62:1195\u20131202","journal-title":"Leuk Lymphoma"},{"key":"7454_CR30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00057711","volume":"39","author":"E Azoulay","year":"2012","unstructured":"Azoulay E, Canet E, Raffoux E, Lengline E, Lemiale V, Vincent F, de Labarthe A, Seguin A, Boissel N, Dombret H, Schlemmer B (2012) Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur Respir J 39:648\u2013653","journal-title":"Eur Respir J"},{"key":"7454_CR31","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00277-023-05119-3","volume":"102","author":"M Cerrano","year":"2023","unstructured":"Cerrano M, Chevret S, Raffoux E, Rabian F, Sebert M, Valade S, Itzykson R, Lemiale V, Ades L, Boissel N, Dombret H, Azoulay E, Lengline E (2023) Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis. Ann Hematol 102:761\u2013768","journal-title":"Ann Hematol"},{"key":"7454_CR32","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V93.8.2730","volume":"93","author":"M Nakagawa","year":"1999","unstructured":"Nakagawa M, Bondy GP, Waisman D, Minshall D, Hogg JC, van Eeden SF (1999) The effect of glucocorticoids on the expression of L-selectin on polymorphonuclear leukocyte. Blood 93:2730\u20132737","journal-title":"Blood"},{"key":"7454_CR33","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH (2011) The tumor lysis syndrome. N Engl J Med 364:1844\u20131854","journal-title":"N Engl J Med"},{"key":"7454_CR34","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00134-019-05768-x","volume":"45","author":"L Zafrani","year":"2019","unstructured":"Zafrani L, Canet E, Darmon M (2019) Understanding tumor lysis syndrome. Intensive Care Med 45:1608\u20131611","journal-title":"Intensive Care Med"},{"key":"7454_CR35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3\u201311","journal-title":"Br J Haematol"},{"key":"7454_CR36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bjh.12415","volume":"162","author":"M Darmon","year":"2013","unstructured":"Darmon M, Vincent F, Camous L, Canet E, Bonmati C, Braun T, Caillot D, Cornillon J, Dimicoli S, Etienne A, Galicier L, Garnier A, Girault S, Hunault-Berger M, Marolleau JP, Moreau P, Raffoux E, Recher C, Thiebaud A, Thieblemont C, Azoulay E, Groupe de Recherche en Reanimation Respiratoire et O-H (2013) Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Reanimation Respiratoire et Onco-Hematologique. Br J Haematol 162:489\u2013497","journal-title":"Br J Haematol"},{"key":"7454_CR37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/10428190903456959","volume":"51","author":"M Darmon","year":"2010","unstructured":"Darmon M, Guichard I, Vincent F, Schlemmer B, Azoulay E (2010) Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma 51:221\u2013227","journal-title":"Leuk Lymphoma"},{"key":"7454_CR38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.13403","volume":"169","author":"GL Jones","year":"2015","unstructured":"Jones GL, Will A, Jackson GH, Webb NJ, Rule S, Committee B, for Standards in H, (2015) Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol 169:661\u2013671","journal-title":"Br J Haematol"},{"key":"7454_CR39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/OTT.S103864","volume":"10","author":"N Alakel","year":"2017","unstructured":"Alakel N, Middeke JM, Schetelig J, Bornhauser M (2017) Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase. Onco Targets Ther 10:597\u2013605","journal-title":"Onco Targets Ther"},{"key":"7454_CR40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1159\/000509934","volume":"45","author":"J Matuszkiewicz-Rowinska","year":"2020","unstructured":"Matuszkiewicz-Rowinska J, Malyszko J (2020) Prevention and treatment of tumor lysis syndrome in the era of onco-nephrology progress. Kidney Blood Press Res 45:645\u2013660","journal-title":"Kidney Blood Press Res"},{"key":"7454_CR41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","volume":"49","author":"J Helms","year":"2023","unstructured":"Helms J, Iba T, Connors JM, Gando S, Levi M, Meziani F, Levy JH (2023) How to manage coagulopathies in critically ill patients. Intensive Care Med 49:273\u2013290","journal-title":"Intensive Care Med"},{"key":"7454_CR42","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1111\/jth.15074","volume":"18","author":"TF Wang","year":"2020","unstructured":"Wang TF, Makar RS, Antic D, Levy JH, Douketis JD, Connors JM, Carrier M, Zwicker JI (2020) Management of hemostatic complications in acute leukemia: guidance from the SSC of the ISTH. J Thromb Haemost 18:3174\u20133183","journal-title":"J Thromb Haemost"},{"key":"7454_CR43","volume":"81","author":"Z Guo","year":"2020","unstructured":"Guo Z, Chen X, Tan Y, Xu Z, Xu L (2020) Coagulopathy in cytogenetically and molecularly distinct acute leukemias at diagnosis: comprehensive study. Blood Cells Mol Dis 81:102393","journal-title":"Blood Cells Mol Dis"},{"key":"7454_CR44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/a-1393-8302","volume":"41","author":"H Ten Cate","year":"2021","unstructured":"Ten Cate H, Leader A (2021) Management of disseminated intravascular coagulation in acute leukemias. Hamostaseologie 41:120\u2013126","journal-title":"Hamostaseologie"},{"key":"7454_CR45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1055\/s-0039-1693478","volume":"45","author":"HC Kwaan","year":"2019","unstructured":"Kwaan HC, Weiss I, Tallman MS (2019) The role of abnormal hemostasis and fibrinolysis in morbidity and mortality of acute promyelocytic leukemia. Semin Thromb Hemost 45:612\u2013621","journal-title":"Semin Thromb Hemost"},{"key":"7454_CR46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on T, Haemostasis (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327\u20131330","journal-title":"Thromb Haemost"},{"key":"7454_CR47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0609.2006.00711.x","volume":"77","author":"M Yanada","year":"2006","unstructured":"Yanada M, Matsushita T, Suzuki M, Kiyoi H, Yamamoto K, Kinoshita T, Kojima T, Saito H, Naoe T (2006) Disseminated intravascular coagulation in acute leukemia: clinical and laboratory features at presentation. Eur J Haematol 77:282\u2013287","journal-title":"Eur J Haematol"},{"key":"7454_CR48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1160\/TH15-09-0740","volume":"115","author":"A Squizzato","year":"2016","unstructured":"Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, Ten Cate H, Thachil J, Levi M, Vicente V, D\u2019Angelo A, Di Nisio M (2016) Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thromb Haemost 115:896\u2013904","journal-title":"Thromb Haemost"},{"key":"7454_CR49","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, Lowenberg B, Naoe T, Lengfelder E, Dohner H, Burnett AK, Chen SJ, Mathews V, Iland H, Rego E, Kantarjian H, Ades L, Avvisati G, Montesinos P, Platzbecker U, Ravandi F, Russell NH, Lo-Coco F (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133:1630\u20131643","journal-title":"Blood"},{"key":"7454_CR50","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1158\/1078-0432.CCR-20-0834","volume":"26","author":"KJ Norsworthy","year":"2020","unstructured":"Norsworthy KJ, Mulkey F, Scott EC, Ward AF, Przepiorka D, Charlab R, Dorff SE, Deisseroth A, Kazandjian D, Sridhara R, Beaver JA, Farrell AT, de Claro RA, Pazdur R (2020) Differentiation syndrome with ivosidenib and enasidenib treatment in patients with relapsed or refractory IDH-mutated AML: a U.S. Food and Drug Administration systematic analysis. Clin Cancer Res 26:4280\u20134288","journal-title":"Clin Cancer Res"},{"key":"7454_CR51","first-page":"328","volume":"136","author":"C Orvain","year":"2020","unstructured":"Orvain C, Balsat M, Tavernier E, Marolleau JP, Pabst T, Chevallier P, de Gunzburg N, Cacheux V, Huguet F, Chantepie S, Caillot D, Chalandon Y, Frayfer J, Bonmati C, Lheritier V, Ifrah N, Dombret H, Boissel N, Hunault-Berger M (2020) Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 study. Blood 136:328\u2013338","journal-title":"Blood"},{"key":"7454_CR52","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","volume":"131","author":"CU Rank","year":"2018","unstructured":"Rank CU, Toft N, Tuckuviene R, Grell K, Nielsen OJ, Frandsen TL, Marquart HVH, Albertsen BK, Tedgard U, Hallbook H, Ruud E, Jarvis KB, Quist-Paulsen P, Huttunen P, Wartiovaara-Kautto U, Jonsson OG, Trakymiene SS, Griskevicius L, Saks K, Punab M, Schmiegelow K (2018) Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years. Blood 131:2475\u20132484","journal-title":"Blood"},{"key":"7454_CR53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-018-0168-2","volume":"16","author":"H Wada","year":"2018","unstructured":"Wada H, Matsumoto T, Suzuki K, Imai H, Katayama N, Iba T, Matsumoto M (2018) Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy. Thromb J 16:14","journal-title":"Thromb J"},{"key":"7454_CR54","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1182\/blood.2019003810","volume":"137","author":"MR Thomas","year":"2021","unstructured":"Thomas MR, Scully M (2021) How I treat microangiopathic hemolytic anemia in patients with cancer. Blood 137:1310\u20131317","journal-title":"Blood"},{"issue":"3","key":"7454_CR55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3390\/healthcare10030557","volume":"10","author":"CK Colonne","year":"2022","unstructured":"Colonne CK, Favaloro EJ, Pasalic L (2022) The intriguing connections between von Willebrand Factor, ADAMTS13 and cancer. Healthcare (Basel) 10(3):557","journal-title":"Healthcare (Basel)"},{"key":"7454_CR56","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/ndt\/gfac213","volume":"38","author":"A Decaestecker","year":"2023","unstructured":"Decaestecker A, Hamroun A, Provot F, Rondeau E, Faguer S, Sallee M, Titeca-Beauport D, Rebibou JM, Forestier A, Azar R, Deltombe C, Wynckel A, Grange S, Fremeaux Bacchi V, Cartery C (2023) Retrospective study of 59 cases of cancer-associated thrombotic microangiopathy: presentation and treatment characteristics. Nephrol Dial Transplant 38:913\u2013921","journal-title":"Nephrol Dial Transplant"},{"key":"7454_CR57","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/bjh.17176","volume":"192","author":"J Schmidt","year":"2021","unstructured":"Schmidt J, Zafrani L, Lemiale V, Stepanian A, Joly B, Azoulay E, Mariotte E (2021) The clinical picture of thrombotic microangiopathy in patients older than 60 years of age. Br J Haematol 192:e25\u2013e28","journal-title":"Br J Haematol"},{"key":"7454_CR58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MD.0b013e3182603598","volume":"91","author":"K Lechner","year":"2012","unstructured":"Lechner K, Obermeier HL (2012) Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases. Medicine (Baltimore) 91:195\u2013205","journal-title":"Medicine (Baltimore)"},{"key":"7454_CR59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2141.2001.02704.x","volume":"113","author":"S Fontana","year":"2001","unstructured":"Fontana S, Gerritsen HE, Kremer Hovinga J, Furlan M, Lammle B (2001) Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease. Br J Haematol 113:100\u2013102","journal-title":"Br J Haematol"},{"key":"7454_CR60","first-page":"E250","volume":"94","author":"JC Yui","year":"2019","unstructured":"Yui JC, Garceau D, Jhaveri KD, Wanchoo R, Bijol V, Glezerman I, Hassoun H, Dispenzieri A, Russell SJ, Leung N (2019) Monoclonal gammopathy-associated thrombotic microangiopathy. Am J Hematol 94:E250\u2013E253","journal-title":"Am J Hematol"},{"key":"7454_CR61","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s00134-019-05736-5","volume":"45","author":"E Azoulay","year":"2019","unstructured":"Azoulay E, Bauer PR, Mariotte E, Russell L, Knoebl P, Martin-Loeches I, Pene F, Puxty K, Povoa P, Barratt-Due A, Garnacho-Montero J, Wendon J, Munshi L, Benoit D, von Bergwelt-Baildon M, Maggiorini M, Coppo P, Cataland S, Veyradier A, Van de Louw A, Nine-i I (2019) Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura. Intensive Care Med 45:1518\u20131539","journal-title":"Intensive Care Med"},{"key":"7454_CR62","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101081","volume":"14","author":"P Valerio","year":"2021","unstructured":"Valerio P, Barreto JP, Ferreira H, Chuva T, Paiva A, Costa JM (2021) Thrombotic microangiopathy in oncology\u2014a review. Transl Oncol 14:101081","journal-title":"Transl Oncol"},{"key":"7454_CR63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccc.2019.12.004","volume":"36","author":"S Valade","year":"2020","unstructured":"Valade S, Mariotte E, Azoulay E (2020) Coagulation disorders in hemophagocytic lymphohistiocytosis\/macrophage activation syndrome. Crit Care Clin 36:415\u2013426","journal-title":"Crit Care Clin"},{"key":"7454_CR64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131","journal-title":"Pediatr Blood Cancer"},{"key":"7454_CR65","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G (2014) Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66:2613\u20132620","journal-title":"Arthritis Rheumatol"},{"key":"7454_CR66","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Rosee","year":"2019","unstructured":"La Rosee P, Horne A, Hines M, von Bahr GT, Machowicz R, Berliner N, Birndt S, Gil-Herrera J, Girschikofsky M, Jordan MB, Kumar A, van Laar JAM, Lachmann G, Nichols KE, Ramanan AV, Wang Y, Wang Z, Janka G, Henter JI (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133:2465\u20132477","journal-title":"Blood"},{"key":"7454_CR67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjh.13102","volume":"168","author":"M Arca","year":"2015","unstructured":"Arca M, Fardet L, Galicier L, Riviere S, Marzac C, Aumont C, Lambotte O, Coppo P (2015) Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol 168:63\u201368","journal-title":"Br J Haematol"},{"key":"7454_CR68","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/j.clml.2020.10.009","volume":"21","author":"B Li","year":"2021","unstructured":"Li B, Guo J, Li T, Gu J, Zeng C, Xiao M, Zhang W, Li Q, Zhou J, Zhou X (2021) Clinical characteristics of hemophagocytic lymphohistiocytosis associated with non-Hodgkin B-cell lymphoma: a multicenter retrospective study. Clin Lymphoma Myeloma Leuk 21:e198\u2013e205","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"7454_CR69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17512433.2021.1901576","volume":"14","author":"C Garonzi","year":"2021","unstructured":"Garonzi C, Chinello M, Cesaro S (2021) Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis. Expert Rev Clin Pharmacol 14:527\u2013534","journal-title":"Expert Rev Clin Pharmacol"},{"key":"7454_CR70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3324\/haematol.2022.281221","volume":"108","author":"G Stalder","year":"2023","unstructured":"Stalder G, Suffiotti M, Segot A, Noto A, Pantaleo G, Spertini O, Obeid M (2023) Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial. Haematologica 108:234\u2013239","journal-title":"Haematologica"},{"key":"7454_CR71","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.14743","volume":"177","author":"JN Gustine","year":"2017","unstructured":"Gustine JN, Meid K, Dubeau T, Hunter ZR, Xu L, Yang G, Ghobrial IM, Treon SP, Castillo JJ (2017) Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstrom macroglobulinaemia. Br J Haematol 177:717\u2013725","journal-title":"Br J Haematol"},{"key":"7454_CR72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fonc.2020.00815","volume":"10","author":"A Weaver","year":"2020","unstructured":"Weaver A, Rubinstein S, Cornell RF (2020) Hyperviscosity syndrome in paraprotein secreting conditions including Waldenstrom macroglobulinemia. Front Oncol 10:815","journal-title":"Front Oncol"},{"key":"7454_CR73","doi-asserted-by":"crossref","first-page":"1069360","DOI":"10.3389\/fimmu.2022.1069360","volume":"13","author":"PE Debureaux","year":"2022","unstructured":"Debureaux PE, Harel S, Parquet N, Lemiale V, Siguret V, Goubeau L, Morin F, Royer B, Cuccuini W, Elessa D, Theves F, Brignier AC, Azoulay E, Arnulf B, Talbot A (2022) Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: a real-life study. Front Immunol 13:1069360","journal-title":"Front Immunol"},{"key":"7454_CR74","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.1965.03080190030008","volume":"192","author":"JL Fahey","year":"1965","unstructured":"Fahey JL, Barth WF, Solomon A (1965) Serum hyperviscosity syndrome. JAMA 192:464\u2013467","journal-title":"JAMA"},{"key":"7454_CR75","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00134-018-5087-y","volume":"44","author":"G Dumas","year":"2018","unstructured":"Dumas G, Gabarre P, Bige N, Maury E (2018) Hyperviscosity syndrome. Intensive Care Med 44:1151\u20131152","journal-title":"Intensive Care Med"},{"key":"7454_CR76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3816\/CLM.2009.n.026","volume":"9","author":"MJ Stone","year":"2009","unstructured":"Stone MJ (2009) Waldenstrom\u2019s macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia. Clin Lymphoma Myeloma 9:97\u201399","journal-title":"Clin Lymphoma Myeloma"},{"key":"7454_CR77","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00134-022-06793-z","volume":"48","author":"PR Bauer","year":"2022","unstructured":"Bauer PR, Ostermann M, Russell L, Robba C, David S, Ferreyro BL, Cid J, Castro P, Juffermans NP, Montini L, Pirani T, Van De Louw A, Nielsen N, Wendon J, Brignier AC, Schetz M, Kielstein JT, Winters JL, Azoulay E, Nine II (2022) Plasma exchange in the intensive care unit: a narrative review. Intensive Care Med 48:1382\u20131396","journal-title":"Intensive Care Med"},{"key":"7454_CR78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajh.24557","volume":"92","author":"MA Gertz","year":"2017","unstructured":"Gertz MA (2017) Waldenstrom macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol 92:209\u2013217","journal-title":"Am J Hematol"},{"key":"7454_CR79","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.kint.2020.11.010","volume":"99","author":"F Bridoux","year":"2021","unstructured":"Bridoux F, Leung N, Belmouaz M, Royal V, Ronco P, Nasr SH, Fermand JP, International K, Monoclonal Gammopathy Research G (2021) Management of acute kidney injury in symptomatic multiple myeloma. Kidney Int 99:570\u2013580","journal-title":"Kidney Int"},{"key":"7454_CR80","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1681\/ASN.2010080857","volume":"22","author":"CA Hutchison","year":"2011","unstructured":"Hutchison CA, Cockwell P, Stringer S, Bradwell A, Cook M, Gertz MA, Dispenzieri A, Winters JL, Kumar S, Rajkumar SV, Kyle RA, Leung N (2011) Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 22:1129\u20131136","journal-title":"J Am Soc Nephrol"},{"key":"7454_CR81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40620-018-0492-4","volume":"32","author":"IJ Sathick","year":"2019","unstructured":"Sathick IJ, Drosou ME, Leung N (2019) Myeloma light chain cast nephropathy, a review. J Nephrol 32:189\u2013198","journal-title":"J Nephrol"},{"key":"7454_CR82","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","volume":"74","author":"MA Perazella","year":"2008","unstructured":"Perazella MA, Markowitz GS (2008) Bisphosphonate nephrotoxicity. Kidney Int 74:1385\u20131393","journal-title":"Kidney Int"},{"key":"7454_CR83","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.20.00298","volume":"38","author":"F Bridoux","year":"2020","unstructured":"Bridoux F, Arnulf B, Karlin L, Blin N, Rabot N, Macro M, Audard V, Belhadj K, Pegourie B, Gobert P, Cornec Le Gall E, Joly B, Karras A, Jaccard A, Augeul-Meunier K, Manier S, Royer B, Caillot D, Tiab M, Delbes S, Suarez F, Vigneau C, Caillard S, Arakelyan-Laboure N, Roos-Weil D, Chevret S, Fermand JP (2020) Randomized trial comparing double versus triple bortezomib-based regimen in patients with multiple myeloma and acute kidney injury due to cast nephropathy. J Clin Oncol 38:2647\u20132657","journal-title":"J Clin Oncol"},{"key":"7454_CR84","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajh.21922","volume":"86","author":"UD Bayraktar","year":"2011","unstructured":"Bayraktar UD, Warsch S, Pereira D (2011) High-dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma. Am J Hematol 86:224\u2013227","journal-title":"Am J Hematol"},{"key":"7454_CR85","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/bloodadvances.2016003269","volume":"1","author":"MA Dimopoulos","year":"2017","unstructured":"Dimopoulos MA, Roussou M, Gavriatopoulou M, Psimenou E, Ziogas D, Eleutherakis-Papaiakovou E, Fotiou D, Migkou M, Kanellias N, Panagiotidis I, Ntalianis A, Papadopoulou E, Stamatelopoulos K, Manios E, Pamboukas C, Kontogiannis S, Terpos E, Kastritis E (2017) Cardiac and renal complications of carfilzomib in patients with multiple myeloma. Blood Adv 1:449\u2013454","journal-title":"Blood Adv"},{"key":"7454_CR86","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00134-008-1320-4","volume":"35","author":"V Peigne","year":"2009","unstructured":"Peigne V, Rusinova K, Karlin L, Darmon M, Fermand JP, Schlemmer B, Azoulay E (2009) Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 35:512\u2013518","journal-title":"Intensive Care Med"}],"updated-by":[{"DOI":"10.1007\/s00134-024-07494-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000}}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07454-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-024-07454-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07454-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T07:02:59Z","timestamp":1719903779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-024-07454-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["7454"],"URL":"https:\/\/doi.org\/10.1007\/s00134-024-07454-z","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00134-024-07494-5","URL":"https:\/\/doi.org\/10.1007\/s00134-024-07494-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}